Synthetic Lethality-based Drugs and Targets Market: Introduction
Synthetic lethality occurs when a combination of two deficiencies arises and results into organismal or cellular death. It was first described by American geneticist Calvin Bridges in the 20th century.
Efficacy in tumor therapy increases by targeting synthetic lethal interaction with drug combination. Synthetic lethality is an important therapeutic option for the treatment of